Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29502635/ below:

Ten Years of Human Papillomavirus Vaccination in the United States

Review

Affiliations

• ¹ National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: lem2@cdc.gov.
• ² Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.
• ³ National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga.
• ⁴ National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.

• PMID: 29502635
• PMCID: PMC11331487
• DOI: 10.1016/j.acap.2017.09.014

Item in Clipboard

Review

Lauri E Markowitz et al. Acad Pediatr. 2018 Mar.

• ¹ National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: lem2@cdc.gov.
• ² Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.
• ³ National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga.
• ⁴ National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.

• PMID: 29502635
• PMCID: PMC11331487
• DOI: 10.1016/j.acap.2017.09.014

Item in Clipboard

Since human papillomavirus (HPV) vaccine was first introduced for females in the United States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed and new data became available. The United States adopted a gender neutral routine HPV immunization policy in 2011, the first country to do so. Vaccination coverage is increasing, although it remains lower than for other vaccines recommended for adolescents. There are various reasons for low coverage, and efforts are ongoing to increase vaccine uptake. The safety profile of HPV vaccine has been well established from 10 years of postlicensure monitoring. Despite low coverage, the early effects of the HPV vaccination program have exceeded expectations.

Keywords: human papillomavirus; human papillomavirus vaccine; immunization program.

Published by Elsevier Inc.

PubMed Disclaimer

The authors have no conflicts of interest to disclose.

Estimated vaccination coverage among adolescents aged…

Estimated vaccination coverage among adolescents aged 13 to 17 years, National Immunization Survey-Teen, United…

Estimated vaccination coverage among adolescents aged 13 to 17 years, National Immunization Survey-Teen, United States, 2006 through 2016. Coverage on the basis of provider records; a revised definition of adequate provider data was used starting in 2013. HPV indicates human papillomavirus vaccine; Tdap, tetanus, diphtheria, and acellular pertussis vaccine; and MenACWY, meningococcal ACWY vaccine.

• Comprehensive control of human papillomavirus infections and related diseases.

  Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Bosch FX, et al. Vaccine. 2013 Nov 22;31 Suppl 8(0 8):I1-31. doi: 10.1016/j.vaccine.2013.07.026. Vaccine. 2013. PMID: 24229716 Free PMC article. Review.

• Comprehensive control of human papillomavirus infections and related diseases.

  Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012. Bosch FX, et al. Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Vaccine. 2013. PMID: 24331745 Review.

• EBCOG position statement: Gender neutral HPV vaccination for young adults.

  Verheijen RHM, Mahmood T, Donders G, Redman CWE, Wood P. Verheijen RHM, et al. Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:187-189. doi: 10.1016/j.ejogrb.2020.01.016. Epub 2020 Jan 16. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31992466 Review.

• [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].

  Malinova M. Malinova M. Akush Ginekol (Sofiia). 2015;54 Suppl 1:25-31. Akush Ginekol (Sofiia). 2015. PMID: 26137767 Bulgarian.

• Cancers attributable to human papillomavirus infection.

  Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Grulich AE, et al. Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020. Sex Health. 2010. PMID: 20719211

• Human Papillomavirus Vaccination After COVID-19.

  Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV. Toh ZQ, et al. JNCI Cancer Spectr. 2021 Mar 2;5(2):pkab011. doi: 10.1093/jncics/pkab011. eCollection 2021 Apr. JNCI Cancer Spectr. 2021. PMID: 33748668 Free PMC article.

• Pediatric HPV vaccination: Provider recommendations matter among hesitant parents.

  Willis DE, Moore R, Selig JP, Shafeek Amin N, Li J, Watson D, Brimberry RK, McElfish PA. Willis DE, et al. Vaccine. 2024 Nov 14;42(25):126166. doi: 10.1016/j.vaccine.2024.126166. Epub 2024 Jul 30. Vaccine. 2024. PMID: 39079809

• Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.

  Kharbanda EO, Vazquez-Benitez G, DeSilva MB, Naleway AL, Klein NP, Hechter RC, Glanz JM, Donahue JG, Jackson LA, Sheth SS, Greenberg V, Panagiotakopoulos L, Mba-Jonas A, Lipkind HS. Kharbanda EO, et al. JAMA Netw Open. 2021 Apr 1;4(4):e214340. doi: 10.1001/jamanetworkopen.2021.4340. JAMA Netw Open. 2021. PMID: 33818618 Free PMC article.

• Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011-2018).

  Issanov A, Karim ME, Aimagambetova G, Dummer TJB. Issanov A, et al. Vaccines (Basel). 2022 Dec 10;10(12):2113. doi: 10.3390/vaccines10122113. Vaccines (Basel). 2022. PMID: 36560523 Free PMC article.

• Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection.

  Li C, Hall TG, Hall JJ, He WQ. Li C, et al. Epidemiol Infect. 2023 Feb 15;151:e37. doi: 10.1017/S0950268823000213. Epidemiol Infect. 2023. PMID: 36789960 Free PMC article.

1. 1. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(suppl 5): F12–F23. - PubMed
2. 1. Centers for Disease Control and Prevention. Number of HPV-associated cancer cases per year. Available at: https://www.cdc.gov/cancer/hpv/statistics/cases.htm. Accessed August 10, 2017.
3. 1. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107:djv086. - PMC - PubMed
4. 1. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(suppl 5):F123–F138. - PMC - PubMed
5. 1. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63:1–30. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3